Rice, Lawrence

Publications

Sort by

Co-Author Network

selected publications

Mycobacterial Infections With Ruxolitinib: A Retrospective Pharmacovigilance Review. Clinical lymphoma, myeloma & leukemia. 2019 Review GET IT
Times cited: 17
The risk of major bleeding in patients with suspected heparin-induced thrombocytopenia. Journal of thrombosis and haemostasis : JTH. 2019 Academic Article GET IT
Times cited: 26
HITs and misses in 100 years of heparin. Hematology. American Society of Hematology. Education Program. 2017 Review GET IT
Times cited: 8
Adult Hemophagocytic Lymphohistiocytosis: More Data; Even More Questions. Critical care medicine. 2016 Editorial Article GET IT
Times cited: 3
Primary thyroid lymphoma presenting as dermatomyositis: a first case and review of the literature. 2016 GET IT
Times cited: 4
A need for a systematic genetic evaluation of hereditary polyuric patients. Clinical kidney journal. 2016 Academic Article GET IT
Acquired and Hereditary Hypercoagulable States in Patients with Continuous Flow Left Ventricular Assist Devices: Prevalence and Thrombotic Complications. Journal of cardiac failure. 2016 Academic Article GET IT
Times cited: 12
How low is too low: Statin induced hemolysis. 2015 GET IT
Times cited: 5
Polycythemia Vera: An Appraisal of the Biology and Management 10 Years After the Discovery of JAK2 V617F. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Review GET IT
Times cited: 49
There Is No Such Thing as a "Positive" Antibody Test: Diagnosing Heparin-Induced Thrombocytopenia in 2015. Chest. 2015 Editorial Article GET IT
Times cited: 10
Sickle cell patients face death in the ICU*. Critical care medicine. 2014 Editorial Article GET IT
Times cited: 1
Progressive anemia and left upper quadrant pain in a patient with polycythemia vera. 2014 GET IT
Times cited: 3
Successful long-term treatment of Philadelphia chromosome-negative myeloproliferative neoplasms with combination of hydroxyurea and anagrelide. Clinical lymphoma, myeloma & leukemia. 2013 Academic Article GET IT
Times cited: 11
Fatal cardiac and renal allograft rejection with lenalidomide therapy for light-chain amyloidosis. 2013 GET IT
Times cited: 18
PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2012 Academic Article GET IT
Times cited: 8
Amyloidosis: changing approaches and outcomes. Methodist DeBakey cardiovascular journal. 2012 Academic Article GET IT
Times cited: 1
The amyloidoses: clinical features, diagnosis and treatment. 2012 GET IT
Times cited: 50
"Surgical" abdomen in a patient with chronic lymphocytic leukemia: a case of acquired angioedema. 2011 GET IT
Times cited: 6
Unusual autoimmune nonhematologic complications in chronic lymphocytic leukemia. 2011 GET IT
Times cited: 21
A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. American journal of therapeutics. 2011 Academic Article GET IT
Times cited: 34
Heparin-induced thrombocytopenia in the cardiac patient: 10 points to help the physician. 2011 GET IT
Times cited: 4
The HIT Expert Probability (HEP) Score: a novel pre-test probability model for heparin-induced thrombocytopenia based on broad expert opinion. Journal of thrombosis and haemostasis : JTH. 2010 Academic Article GET IT
Times cited: 209
Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis. Clinical therapeutics. 2010 Academic Article GET IT
Times cited: 15
Enhanced antimyeloma cytotoxicity by the combination of arsenic trioxide and bortezomib is further potentiated by p38 MAPK inhibition. Leukemia research. 2009 Academic Article GET IT
Times cited: 40
Treatment of immune thrombocytopenic purpura: focus on eltrombopag. Biologics : targets & therapy. 2009 Academic Article GET IT
Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients. American journal of hematology. 2009 Letter GET IT
Times cited: 6
Changes of red blood cell surface markers in a blood doping model of neocytolysis. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2009 Academic Article GET IT
Times cited: 17
Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: a computer-assisted image analysis study. Pathology, research and practice. 2009 Academic Article GET IT
Times cited: 8
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry. American heart journal. 2009 Academic Article GET IT
Times cited: 39
Improved quality of life for romiplostim-treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo-controlled trials. British journal of haematology. 2008 Academic Article GET IT
Times cited: 120
p38 mitogen-activated protein kinase has different degrees of activation in myeloproliferative disorders and myelodysplastic syndromes. American journal of clinical pathology. 2008 Academic Article GET IT
Times cited: 12
Severe iron overload with a novel aminolevulinate synthase mutation and hepatitis C infection. A case report. 2008 GET IT
Times cited: 8
The implication of identifying JAK2 ( V617F ) in myeloproliferative neoplasms and myelodysplastic syndromes with bone marrow fibrosis. Journal of hematopathology. 2008 Academic Article GET IT
Times cited: 10
The role of beta-catenin in chronic myeloproliferative disorders. Human pathology. 2008 Academic Article GET IT
Times cited: 7
Argatroban therapy in heparin-induced thrombocytopenia. Expert review of clinical pharmacology. 2008 Academic Article GET IT
Times cited: 3
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet (London, England). 2008 Academic Article GET IT
Times cited: 710
Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy. Archives of internal medicine. 2008 Academic Article GET IT
Times cited: 87
P38 MAPK inhibition enhancing ATO-induced cytotoxicity against multiple myeloma cells. British journal of haematology. 2008 Academic Article GET IT
Times cited: 45
Polymorphisms in TGFbeta and TNFalpha are associated with the myelodysplastic syndrome phenotype. Archives of pathology & laboratory medicine. 2007 Academic Article GET IT
Times cited: 24
Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia. Journal of clinical pharmacology. 2007 Academic Article GET IT
Times cited: 29
Limb amputation in hemoglobin SC disease after application of ice and elevation. 2007 GET IT
Times cited: 6
Drug evaluation: AMG-531 for the treatment of thrombocytopenias. Current opinion in investigational drugs (London, England : 2000). 2006 Review GET IT
Times cited: 14
Current management of the myeloproliferative disorders: a case-based review. Archives of pathology & laboratory medicine. 2006 Review GET IT
Times cited: 13
Novel ADAMTS-13 mutations in an adult with delayed onset thrombotic thrombocytopenic purpura. 2006 GET IT
Times cited: 56
Necrobiotic xanthogranuloma with posterior scleritis. 2006 GET IT
Times cited: 14
Argatroban for suspected heparin-induced thrombocytopenia: contemporary experience at a large teaching hospital. Journal of intensive care medicine. 2006 Academic Article GET IT
Times cited: 31
Acute respiratory distress syndrome after rituximab infusion. 2005 GET IT
Times cited: 21
Responses to human CD40 ligand/human interleukin-2 autologous cell vaccine in patients with B-cell chronic lymphocytic leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 79
Evolving management strategies for heparin-induced thrombocytopenia. Seminars in hematology. 2005 Review GET IT
Times cited: 13
Introduction. What's happening with heparin-induced thrombocytopenia: emerging preventive, diagnostic, and management strategies. Seminars in hematology. 2005 Academic Article GET IT
Cases of heparin-induced thrombocytopenia elucidate the syndrome. 2005 GET IT
Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: a registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The Complication After Thrombocytopenia Caused by Heparin (CATCH) Registry steering committee. Journal of thrombosis and thrombolysis. 2005 Academic Article GET IT
Times cited: 32
Every case of essential thrombocythemia should be tested for the Philadelphia chromosome. 2005 GET IT
Times cited: 26
The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology. 2005 Review GET IT
Times cited: 144
Pathologic quiz case: a 64-year-old man with hematuria, intracranial hemorrhage, and severe coagulation abnormalities. Long-acting warfarin-like rodenticide toxicity. 2004 GET IT
Times cited: 4
Heparin-induced thrombocytopenia: myths and misconceptions (that will cause trouble for you and your patient). Archives of internal medicine. 2004 Review GET IT
Times cited: 74
Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia. European journal of haematology. 2004 Review GET IT
Times cited: 26
Trousseau-like venous thromboemboli with benign ovarian tumors. 2004 GET IT
Times cited: 1
Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia. 2004 GET IT
Times cited: 166
Erythropoietin withdrawal leads to the destruction of young red cells at the endothelial-macrophage interface. Current pharmaceutical design. 2004 Review GET IT
Times cited: 39
Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures. 2003 GET IT
Times cited: 36
Laparoscopic splenectomy for chronic recurrent thrombotic thrombocytopenic purpura. 2003 GET IT
Times cited: 7
Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes. Postgraduate medicine. 2002 Academic Article GET IT
Delayed-onset heparin-induced thrombocytopenia. 2002 GET IT
Times cited: 221
Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy. 2001 GET IT
Times cited: 48
Erythropoietin withdrawal alters interactions between young red blood cells, splenic endothelial cells, and macrophages: an in vitro model of neocytolysis. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. 2001 Academic Article GET IT
Times cited: 37
Neocytolysis on descent from altitude: a newly recognized mechanism for the control of red cell mass. Annals of internal medicine. 2001 Academic Article GET IT
Times cited: 117
Surreptitious bleeding in surgery: a major challenge in coagulation. 2000 GET IT
Times cited: 8
Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Annals of internal medicine. 2000 Academic Article GET IT
Times cited: 205
Modulation of red cell mass by neocytolysis in space and on Earth. Pflugers Archiv : European journal of physiology. 2000 Review GET IT
Times cited: 47
Surgery-associated factor VIII inhibitors in patients without hemophilia. 1999 GET IT
Times cited: 13
Pentosan induced cerebral sagittal sinus thrombosis: a variant of heparin induced thrombocytopenia. 1998 GET IT
Times cited: 9
The clinical behavior of localized and multicentric Castleman disease. Annals of internal medicine. 1998 Academic Article GET IT
Times cited: 377
Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. American journal of hematology. 1998 Academic Article GET IT
Times cited: 93
Splenectomy for relapsing thrombotic thrombocytopenic purpura. Annals of internal medicine. 1997 Letter GET IT
Neocytolysis: physiological down-regulator of red-cell mass. Lancet (London, England). 1997 Review GET IT
Times cited: 129
Aplastic anemia in eosinophilic fasciitis: responses to immunosuppression and marrow transplantation. 1997 GET IT
Times cited: 20
Fatal cerebral venous thrombosis as the initial manifestation of the antiphospholipid syndrome. 1996 GET IT
Times cited: 10
Multiple myeloma after cardiac transplantation: an unusual form of posttransplant lymphoproliferative disorder. 1994 GET IT
Times cited: 26
Assessment of tissue iron overload by nuclear magnetic resonance imaging. The American journal of medicine. 1989 Academic Article GET IT
Times cited: 106
Treatment of malignant carcinoid syndrome with a long-acting somatostatin analogue. 1989 GET IT
Times cited: 8
Ringed sideroblasts in primary myelodysplasia. Leukemic propensity and prognostic factors. Archives of internal medicine. 1988 Academic Article GET IT
Times cited: 6
Manifestations of sepsis. Archives of internal medicine. 1987 Review GET IT
Times cited: 135
Plasma cell dyscrasia with marrow fibrosis. Clinicopathologic syndrome. 1985 GET IT
Times cited: 30
Multiple myeloma in a homosexual man with chronic lymphadenopathy. 1985 GET IT
Times cited: 30
Morbidity of sickle cell trait at high altitude. 1984 GET IT
Times cited: 13
Suppression of lymphocyte responses by monocytes with untreated and treated multiple myeloma. Blood. 1982 Academic Article GET IT
Times cited: 10
Erythrocytosis and marked leukocytosis in overlapping myeloproliferative diseases. 1982 GET IT
Times cited: 3
Angioimmunoblastic lymphadenopathy with hypogammaglobulinemia. Possible role of monocyte suppression. 1982 GET IT
Times cited: 6
Granulomatous infections complicating hairy cell leukemia. 1982 GET IT
Times cited: 36
Acquired Pelger-Huët nuclear anomaly with tuberculosis. 1982 GET IT
Times cited: 10
Suppression of lymphocyte responses by monocytoid cells does not require cell-cell contact. Cellular immunology. 1981 Academic Article GET IT
Times cited: 7
Can heparin cause clotting? 1981 GET IT
Times cited: 5
Transplantation of bone marrow: graft-vs.-host disease. 1981 GET IT
Serum haptoglobin in hemolytic disease. JAMA. 1980 Letter GET IT
Times cited: 2
Spectrum of immunodeficiencies with Hodgkin's disease. The Journal of clinical investigation. 1980 Academic Article GET IT
Times cited: 39
Impact of Hodgkin's disease upon the immune system. Seminars in oncology. 1980 Review GET IT
Times cited: 46
Three suppressor systems in human blood that modulate lymphoproliferation. Journal of immunology (Baltimore, Md. : 1950). 1979 Academic Article GET IT
Times cited: 85

more ...

less ...

Background

education and training

M.D., Emory University School of Medicine 1974
B.S., University of Florida 1970

Contact

full name

Lawrence Rice

primary email

lrice@tmhs.org

VIVO Weill Cornell Medical College

Lawrence Rice Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email